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Abstract
Background: Pollen Typhae total flavone (PTF), the extract from Pollen Typhae, a Chinese herbal medicine, has been reported to improve
insulin resistance in type 2 diabetic rats, but the potential mechanisms keep unclear.
Materials and Methods: Type 2 diabetic model rats were induced by high-fat diet and low-dose streptozotocin, and then were administered
PTF by intragastrical gavage. After treatment for 4 weeks, insulin receptor-β level in adipose tissues was determined by ELISA, and the protein 
expression was analyzed by western blotting.
Results: Administration of PTF increased insulin receptor-β level and enhanced β-arrestin-2 protein expression in adipose tissues of type 2 
diabetic rats. Although having no effect on the protein expression of Src or Akt, PTF promoted phosphorylation of Src at Tyr416 and Akt at
Ser473.
Conclusion: The results indicate that PTF has beneficial effects on the β-arrestin-2/Src/Akt signaling in adipose tissues of type 2 diabetic rats, 
implying the underlying mechanisms of PTF in ameliorating insulin resistance.
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Introduction
Pollen Typhae, the pollen of all species of Typha such as T. angustifolia, T. latifolia, T. angustata and T. orientalis, is a Chinese herbal
medicine. Pollen Typhae has been widely used to treat type 2 diabetes and other diseases characterized by insulin resistance such as metabolic
syndrome and non-alcohol fatty liver disease in China. We have ever reported that Pollen Typhae total flavone (PTF), the extract from Pollen
Typhae which mainly contains typhaneoside and other constituents (Feng et al. 2012a), ameliorates insulin resistance in type 2 diabetic rats
(Feng et al. 2014), but the potential mechanisms remain to be fully elucidated.
Insulin resistance, a hallmark of type 2 diabetes, is simply the defect of insulin action in triggering insulin signaling in peripheral
insulin-sensitive tissues, including adipose tissues, liver, and skeletal muscles. In addition to phosphatidylinositol-3 kinase (PI3K) pathway,
another insulin signaling has been recently discovered (Luan et al. 2009). Upon insulin stimulation, β-arrestin-2 - an important adaptor in 
mediating cellular signal pathway - scaffolds Src and Akt to upstream insulin receptor (InsR), thus promoting the formation of a β-arrestin-2 
signal complex (Luan et al. 2009). In the complex Src phosphorylates Akt on Tyr315/326, which strengthens phosphorylation of Akt at
Thr308/Ser473. Phosphorylated Akt mediates downstream kinases and transcription factors, thus regulating most of the metabolic actions of
insulin (Jiang and Qiu 2003; Luan et al. 2009; Feng et al. 2011). Deficiency of β-arrestin-2 causes inability of the complex formation and 
dysfunction of the signaling, thereby resulting in insulin resistance. Overexpression of β-arrestin-2, however, promotes the formation of the 
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β-arrestin-2 complex, thus improving insulin resistance in animals (Luan et al. 2009). Inhibition of Src by PP2 leads to a reduction in 
phosphorylation of Akt at Thr308/Ser473 in C2C12 myotubes and Hep3B hepatocytes, thereby decreasing glucose uptake and insulin sensitivity
(Luan et al. 2009; Feng et al. 2012b). It is well known that palmitate, a saturated fatty acid, contributes to insulin resistance involving complex
mechanisms (Ishii et al. 2015). Moreover, although having no effect on the protein expression of β-arrestin-2, palmitate causes insulin resistance 
through, at least in part, down-regulating the phosphorylation of Src and Src-mediated phosphorylation of Akt in C2C12 myotubes (Feng et al.
2012b).
In order to reveal the underlying molecular mechanisms of PTF in improving insulin resistance, the study aimed to observe the effects of
PTF on the β-arrestin-2/Src/Akt signaling in type 2 diabetic rats induced by high-fat diet and low-dose streptozotocin. The determination InsR-β 
level was also aimed at in the study.
Materials and Methods
Animal Model and Treatment
Male Sprague-Dawley rats (weight 160-200 g) were purchased from Hunan Slaccas Jingda Laboratory Animal Company Limited (Changsha,
China). Normal pellet diet with 4.6% fat (about 10% of calories as fat) and high fat diet (about 40% of calories as fat) were provided by
Shanghai Slaccas Laboratory Animal Company Limited (Shanghai, China). Type 2 diabetic model rats were induced by high-fat diet and
low-dose streptozotocin (35 mg/kg, i.p.) in line with our previous description (Feng et al. 2014). The model rats were randomly assigned to 3
subgroups: the model group (MOD, n = 8), the Pollen Typhae total flavone group (PTF, n = 9), and the rosiglitazone group (ROS, n = 8). The
control group (CON, n = 9; non-diabetic rats) for type 2 diabetic rats was set up. The rats in the PTF group and the rosiglitazone group were
given 200 mg/kg·d PTF (extracted from the pollen of T. angustifolia) and 4 mg/kg·d rosiglitazone (dissolved in purified water) by intragastric
administration, respectively; while the rats in the control group and the model group received an equal volume of purified water per day,
respectively. After treatment for 4 weeks, the rats were anesthetized with pentobarbital sodium (40 mg/kg, i.p.), and visceral adipose tissues in
each group were collected and kept in -80°C fridge. Then, relative indexes were checked. All experimental procedures were in accordance with
the internationally accepted principles for laboratory animal use and care. The study was approved by the Ethics Committee of Guangxi
University of Chinese Medicine.
Reagents
Antibodies directed against β-arrestin-2, Akt (total), Akt (phosphorylated Thr473), and Src (phosphorylated Tyr416) were purchased from 
Cell Signaling Technology (Danvers, MA, USA). Antibody to Src was obtained from Epitomics (Burlingame, CA, USA). Secondary horseradish
peroxidase (HRP)-conjugated antibodies and streptozotocin were from Sigma (St. Louis, MO, USA). ECL Western Blotting Substrate was
acquired from Pierce (Rockford, IL, USA). Rat InsR-β ELISA Kit was from Bio-Swamp Life Science (Shanghai, China). PTF was provided and 
determined by Xi’an Salao Bio-Technology Company Limited (Xi’an China). Rosiglitazone was from Glaxo Company Limited (Tianjin, China).
Protein assay kit, phosphate buffered saline (PBS), and RIPA lysis buffer for western blot were obtained from Beyotime Institute of
Biotechnology Co., Ltd. (Shanghai, China).
Determination of InsR-β 
Adipose tissues was homogenized with PBS, and subsequently centrifuged to remove the tissue debris at 3,000 rpm for 5 min at 4°C. The
protein concentration of supernatant was analyzed using a BCA protein assay kit. Then, InsR-β was measured by ELISA per the manufacturer's 
instructions.
Western Blot Analysis
The protein expression in adipose tissues was analyzed by western blotting according to a previously described procedure with some
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modifications (Feng et al. 2012a). Briefly, tissue lysate was prepared using RIPA lysis buffer, and supernatant was collected after centrifugation
(12,000 rpm for 5 min, 4°C). Then, the protein concentration of each sample supernatant was determined using protein assay kit. The protein
was separated via SDS-PAGE and electrophoretically transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). The
membranes were incubated with the primary antibodies overnight at 4 °C and then with the appropriate secondary HRP-conjugated antibodies
for 1-2 h at room temperature. The targeted proteins were visualized by incubation with Pierce ECL Western Blotting Substrate.
Results and Discussion
InsR is comprised of two intracellular β subunits and two extracellular α subunits - β subunits are auto-phosphorylated on tyrosine upon 
insulin binding to InsR. Recent study reported that the protein expression of InsR-β was significantly decreased in skeletal muscle of type 2 
diabetic rats (Dong et al. 2013). In this study, InsR-β level was also, to some extent, reduced in adipose tissues of type 2 diabetic rats and 
administration of PTF significantly increased InsR-β level (Fig. 1). Furthermore, we have ever reported that PTF promotes phosphorylation of 
InsR-β in an insulin-dependent manner in C2C12 myotubes in vitro (Feng et al. 2012a). Although, β-arrestin-2 level in the model group was not 
markedly reduced when compared with the control group, PTF treatment significantly increased β-arrestin-2 protein expression in the rats’ 
adipose tissues when compared with the model group (Fig. 2). According to the past reports (Luan et al. 2009; Feng et al. 2012b), β-arrestin-2 
protein expression is not changed in adipose tissues of high-fat diet-induced insulin-resistant mice and palmitate-induced insulin-resistant
skeletal muscle cells, which is consistent with this study. Because of the key role of β-arrestin-2 in regulating the insulin signaling and an 
increase in β-arrestin-2 protein expression by PTF, it is likely that PTF has beneficial effects on the β-arrestin-2/Src/Akt signaling.  
Figure 1: Effect of PTF on InsR-β level in adipose tissues of type 2 diabetes rats. After treatment, InsR-β level in adipose tissues was determined 
using ELISA. The data are presented as means ± standard error (SE). The significance among multiple groups was analyzed by one-way
analysis of variance (ANOVA) followed by LSD test. P < 0.05 was considered to be statistically significant. *P < 0.05, **P < 0.01 vs. model
group (MOD).
It is confirmed that Akt phosphorylation at Thr308/Ser473 is significantly decreased in insulin-targeted organs of type 2 diabetic animals,
while total Akt protein expression keeps no changes or is decreased (Yuan et al. 2007; Gandhi et al. 2013). As a protein tyrosine kinase, the
activity of Src is regulated by tyrosine phosphorylation. Phosphorylation of Src at Tyr527 means less activity, while phosphorylation at Tyr416
increases the enzyme activity (Hunter 1987). Src can be directly associated with Akt through the interaction between its SH3 domain and a
conserved proline-rich motif (PXXP) in the C-terminal regulatory region of Akt, and induces phosphorylation of Tyr315 in Akt, thus promoting
Akt phosphorylation at Thr308/Ser473 (Jiang and Qiu 2003; Lodeiro et al. 2009). Therefore, we analyzed the effects of PTF on the protein
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expression of Src and Akt. In this study, the protein expression of Src or Akt was not remarkably changed in the model group when compared
with the control group, and administration of PTF did not increase the protein expression. The phosphorylation of Src at Tyr416 and Akt at
Ser473, however, was markedly decreased in the model group rats, and PTF treatment significantly enhanced the phosphorylation (Fig. 2). In
palmitate-induced insulin-resistant C2C12 myotubes, insulin-stimulated phosphorylation of Src at Tyr416 and Akt at Thr308/Ser473 is
remarkably reduced, with no changes in their total protein expression (Feng et al. 2012b). And in aortic strips of type 2 diabetic rats, the
phosphorylation of Src and Akt dependent of insulin triggering is also decreased (Nemoto et al. 2011). These were all consistent with this study.
It is well known that rosiglitazone, an insulin sensitizer, ameliorates insulin resistance by activating peroxisome proliferator-activated
receptors-γ, thereby enhancing the activity of the PI3K pathway, an important insulin signal pathway. In the study, rosiglitazone was taken as a 
control for PTF, and enhanced InsR-β level and Akt phosphorylation when compared with the model group, but could not increase β-arrestin-2 
protein expression or Src phosphorylation (Fig. 2), which was different from PTF.
Figure 2: Effects of PTF on protein expression of β-arrestin-2, Src, and Akt as well as their phosphorylation in adipose tissues of type 2 diabetic 
rats.
After treatment, the protein expression in adipose tissues was analyzed by western blotting as materials and methods described.
Conclusion
Type 2 diabetes often coexists with obesity, with more adipose. Adipose tissues, the key insulin targeted tissues, play an important role in
maintaining insulin-mediated metabolic action, including glucose uptake and disposal as well as fat mobilization (He et al. 2006; Mitrou et al.
2009). Dysfunction of insulin pathway in adipose tissues causes insulin resistance. PTF promotes glucose uptake and consumption in 3T3-L1
adipocytes and C2C12 myotubes in vitro (He et al. 2006; Feng et al. 2012a), suggesting the potential anti-insulin resistant action of PTF. In vivo,
PTF improves insulin resistance in type 2 diabetic rats induced by high-fat diet and low-dose streptozotocin (Feng et al. 2014). Additionally,
PTF can not affect PI3K activity in C2C12 myotubes (Feng et al. 2012a), a critical node in PI3K pathway. Here, PTF increased InsR-β level, 
enhanced β-arrestin-2 protein expression, and promoted phosphorylation of Src and Akt in adipose tissues of type 2 diabetic rats, implying the 
beneficial effects of PTF on the β-arrestin-2/Src/Akt signaling. Together, PTF ameliorates insulin resistance through, at least in part, the 
β-arrestin-2/Src/Akt signaling in adipose tissues of type 2 diabetic rats. 
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